Sally Del Principe

Corporate Officer/Principal at Lupton del Principe Associates Ltd.

67 year

Commercial Services

Profile

Sally Del Principe is currently a Partner at Lupton del Principe Associates Ltd.
where she has worked since 1992.
Previously, she worked as the Chief Financial Officer at HIV-VAC, Inc. from 2001 to 2010.

Sally Del Principe active positions

Companies	Position	Start
Lupton del Principe Associates Ltd.	Corporate Officer/Principal	09/04/2010

All active positions of Sally Del Principe

Former positions of Sally Del Principe

Companies	Position	End
HIV-VAC, Inc. HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA.	Director of Finance/CFO	28/10/2010

See the detail of Sally Del Principe's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sally Del Principe's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
HIV-VAC, Inc. HIV-VAC, Inc. Miscellaneous Commercial ServicesCommercial Services HIV-VAC, Inc. develops and markets proposed vaccine designed to combat HIV/AIDS. This proposed vaccine, which is called NFU.Ac.HIV, was developed by Dr. Gordon Skinner, director of research, through the University of Birmingham, in the U.K. The proposed vaccine was licensed to Intracell Vaccines Limited from the University of Birmingham. The company was founded in 1997 and is headquartered in Ontario, CA.	Commercial Services
Lupton del Principe Associates Ltd.